WWD reported on how GLP-1 weight-loss medications are reshaping shopping and return behavior among men, challenging the long-held assumption that women drive most apparel returns. The article cited a ReturnPro survey of 500 U.S. adults currently or recently taking GLP-1 drugs, which found that men on medications such as Ozempic or Wegovy are now returning apparel and purchasing multiple sizes at notably higher rates. ReturnPro CEO Sender Shamiss was quoted warning that GLP-1 drugs are reshaping body sizes for millions of shoppers faster than most retail systems were built to handle. The coverage underscores ReturnPro's ongoing research into how shifting body sizes are straining retail returns infrastructure and sizing strategy across categories.
